5399-63-3

Usage

Uses

Used in Chemical Synthesis:
4-SULFOBENZOIC ACID MONOPOTASSIUM SALT is used as a reactant for the synthesis of Potassium and Rubidium Arenesulfonates. These compounds exhibit coordination behavior towards anions, making them valuable in the development of new materials and chemical processes.
Used in Polymer Industry:
In the polymer industry, 4-SULFOBENZOIC ACID MONOPOTASSIUM SALT is used as an intercalating compound to improve clay exfoliation in the synthesis of poly(butylene terephthalate) (PBT) nanocomposites. This application enhances the properties of the resulting material, such as its mechanical strength and thermal stability.
Used in Pharmaceutical and Biomedical Applications:
While not explicitly mentioned in the provided materials, 4-SULFOBENZOIC ACID MONOPOTASSIUM SALT, due to its chemical structure, may have potential applications in the pharmaceutical and biomedical fields. Its ability to coordinate with anions could make it a candidate for drug delivery systems or as a component in the development of new therapeutic agents.

InChI:InChI=1/C7H6O5S/c8-7(9)5-1-3-6(4-2-5)13(10,11)12/h1-4H,(H,8,9)(H,10,11,12)/p-2

Upstream product

• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 94781-74-5 1,3-dimethyl-6-amino-5-(p-sulfobenzamido)uracil 
• 94781-79-0 1,3-dipropyl-6-amino-5-(p-sulfobenzamido)uracil 
• 152529-72-1 6-amino-3-propyl-5-(4-sulfophenyl)carboxamidouracil 
• 17202-49-2 p-carboxybenzenesulfonyl azide 
• 10130-89-9 p-carboxyphenylsulfonyl chloride 
• 859691-36-4 4-pentafluorophenyloxysulfonyl-benzoic acid pentafluorophenyl ester 
• 80206-91-3 8-(p-sulphophenyl)theophylline 
• 120362-47-2 8-(p-Sulfophenyl)caffeine 
• 152529-79-8 4-(2,3,6,7-tetrahydro-2,6-dioxo-1-propyl-1H-purin-8-yl)benzenesulfonic acid 
• 666715-86-2 4-[[m-nitrophenoxy]sulfonyl]benzoic acid 
• 666715-89-5 4-(1-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-benzenesulfonic acid 
• 666715-88-4 4-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-benzenesulfonic acid 3-nitro-phenyl ester 
• 666716-02-5 4-(1-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-benzenesulfonic acid 3-nitro-phenyl ester 
• 666715-92-0 1,3-dimethyl-8-[4-[[[p-nitrophenyl]oxy]sulfonyl]phenyl]xanthine 

Relevant academic research and scientific papers

Degradation of sodium 4-dodecylbenzenesulphonate photoinduced by Fe(III) in aqueous solution

The Fe(III)-photoinduced degradation of 4-dodecylbenzenesulphonate (DBS) in aqueous solution was investigated. The mixing of DBS (1 mm) and Fe(III) (1 mm) solutions immediately led to the formation of a precipitate that contained DBS and monomeric Fe(OH)2+, the predominant Fe(III) species. Both species were also present in the supernatant. Irradiation of the supernatant solution resulted in a photoredox process that yielded Fe(II) and ·OH radicals. The disappearance of DBS was shown to involve only attack by ·OH radicals; the quantum yield of DBS disappearance is similar to the quantum yield of ·OH radical formation. A wavelength effect was also observed; the rate of DBS disappearance was higher for shorter wavelength irradiation. Five photoproducts, all containing the benzene sulphonate group, were identified. ·OH radicals preferentially abstract hydrogen from the carbon in the α position of the aromatic ring. The results show that the Fe(III)-photoinduced degradation of DBS could be used as an alternative method for polluted water treatment. (C) 2000 Elsevier Science Ltd.

Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex

Based on the supramolecular interaction between vancomycin (Van), an antibiotic glycopeptide, and D-Ala-D-Ala (DADA) dipeptides, a novel class of artificial metalloenzymes was synthesized and characterized. The presence of an iridium(III) ligand at the N-terminus of DADA allowed the use of the metalloenzyme as a catalyst in the asymmetric transfer hydrogenation of cyclic imines. In particular, the type of link between DADA and the metal-chelating moiety was found to be fundamental for inducing asymmetry in the reaction outcome, as highlighted by both computational studies and catalytic results. Using the [IrCp*(m-I)Cl]Cl Van complex in 0.1 M CH3COONa buffer at pH 5, a significant 70% (S) e.e. was obtained in the reduction of quinaldine B.

Estriol and estetrol prodrugs

This invention provides estriol and estetrol prodrugs of general formula (I), in which group Y is bonded to the steroid process for their production, pharmaceutical compositions that contain these compounds, as well as their use for the production of pharmaceutical agents with estrogenic action.